These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 37288826)
21. Predictive factors for blastoid transformation in the common variant of mantle cell lymphoma. Räty R; Franssila K; Jansson SE; Joensuu H; Wartiovaara-Kautto U; Elonen E Eur J Cancer; 2003 Feb; 39(3):321-9. PubMed ID: 12565984 [TBL] [Abstract][Full Text] [Related]
22. Increased expression of Ki-67 in mantle cell lymphoma is associated with de-regulation of several cell cycle regulatory components, as identified by global gene expression analysis. Ek S; Björck E; Porwit-MacDonald A; Nordenskjöld M; Borrebaeck CA Haematologica; 2004 Jun; 89(6):686-95. PubMed ID: 15194536 [TBL] [Abstract][Full Text] [Related]
23. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management. Vose JM Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091 [TBL] [Abstract][Full Text] [Related]
24. Blastoid Mantle Cell Lymphoma. Jain P; Wang M Hematol Oncol Clin North Am; 2020 Oct; 34(5):941-956. PubMed ID: 32861288 [TBL] [Abstract][Full Text] [Related]
25. IgV H mutations in blastoid mantle cell lymphoma characterize a subgroup with a tendency to more favourable clinical outcome. Cogliatti SB; Bertoni F; Zimmermann DR; Henz S; Diss TC; Ghielmini M; Schmid U J Pathol; 2005 Jul; 206(3):320-7. PubMed ID: 15887292 [TBL] [Abstract][Full Text] [Related]
26. TP53 mutation is frequent in mantle cell lymphoma with EZH2 expression and have dismal outcome when both are present. Kim DH; Siddiqui S; Jain P; Wang M; Thakral B; Li S; Miranda R; Vega F; Medeiros LJ; Ok CY Hum Pathol; 2024 Apr; 146():1-7. PubMed ID: 38460798 [TBL] [Abstract][Full Text] [Related]
27. Smoldering mantle cell lymphoma. Ye H; Desai A; Zeng D; Nomie K; Romaguera J; Ahmed M; Wang ML J Exp Clin Cancer Res; 2017 Dec; 36(1):185. PubMed ID: 29246179 [TBL] [Abstract][Full Text] [Related]
28. Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma. Chiarle R; Budel LM; Skolnik J; Frizzera G; Chilosi M; Corato A; Pizzolo G; Magidson J; Montagnoli A; Pagano M; Maes B; De Wolf-Peeters C; Inghirami G Blood; 2000 Jan; 95(2):619-26. PubMed ID: 10627471 [TBL] [Abstract][Full Text] [Related]
29. Prognostic value and computer image analysis of p53 in mantle cell lymphoma. Zhang YH; Gao LM; Xiang XY; Zhang WY; Liu WP Ann Hematol; 2022 Oct; 101(10):2271-2279. PubMed ID: 35918462 [TBL] [Abstract][Full Text] [Related]
30. NOTCH Signaling in Mantle Cell Lymphoma: Biological and Clinical Implications. Deshotels L; Safa FM; Saba NS Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373427 [TBL] [Abstract][Full Text] [Related]
31. Deep Learning-Based Nuclear Morphometry Reveals an Independent Prognostic Factor in Mantle Cell Lymphoma. Chuang WY; Yu WH; Lee YC; Zhang QY; Chang H; Shih LY; Yeh CJ; Lin SM; Chang SH; Ueng SH; Wang TH; Hsueh C; Kuo CF; Chuang SS; Yeh CY Am J Pathol; 2022 Dec; 192(12):1763-1778. PubMed ID: 36150505 [TBL] [Abstract][Full Text] [Related]
32. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression. Zeng W; Fu K; Quintanilla-Fend L; Lim M; Ondrejka S; Hsi ED Am J Surg Pathol; 2012 Feb; 36(2):214-9. PubMed ID: 22251940 [TBL] [Abstract][Full Text] [Related]
33. Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BV. de Vos S; Krug U; Hofmann WK; Pinkus GS; Swerdlow SH; Wachsman W; Grogan TM; Said JW; Koeffler HP Diagn Mol Pathol; 2003 Mar; 12(1):35-43. PubMed ID: 12605034 [TBL] [Abstract][Full Text] [Related]
34. Differential expression of CKS-1B in typical and blastoid variants of mantle cell lymphoma. Akyurek N; Drakos E; Giaslakiotis K; Knoblock RJ; Abruzzo LV; Ning Y; Rassidakis GZ; Medeiros LJ Hum Pathol; 2010 Oct; 41(10):1448-55. PubMed ID: 20688354 [TBL] [Abstract][Full Text] [Related]
40. An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10. Morice WG; Hodnefield JM; Kurtin PJ; Hanson CA Am J Clin Pathol; 2004 Jul; 122(1):122-7. PubMed ID: 15272540 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]